BONE BIOLOGICS CORP's ticker is and the CUSIP is 098070303. A total of 13 filers reported holding BONE BIOLOGICS CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3 | – | 15,291 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,237,205 | $259,442 | 0.23% |
| Walleye Capital LLC | 830,245 | $169,785 | 0.00% |
| Warberg Asset Management LLC | 30,000 | $6,291 | 0.00% |
| UBS Group AG | 15,263 | $3,205 | 0.00% |
| WELLS FARGO & COMPANY/MN | 47 | $10 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 47,074 | $10 | 0.00% |
| MORGAN STANLEY | 10 | $2 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 52,541 | $10,745 | 0.00% |
| HRT FINANCIAL LP | 17,260 | $3 | 0.00% |